NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-118-2023-2-EP-01 Vaccine for Cats to Block Toxoplasma Gondii Oocyst Shedding and Transmission EP National Stage 24737579.3 Pending
NIAID E-026-2026-0-PC-01 An intranasal nozzle PCT PCT PCT/US2025/056239 Pending
NCI E-132-2023-0-AU-01 T CELL RECEPTORS TARGETING RAS WITH G12D, G12R, OR G12V MUTATION AU National Stage 2024309123 Pending
NCI E-023-2024-0-PC-01 VIRUS ANTIGEN-DERIVED IMMUNOGENIC PEPTIDES AND THEIR USE FOR THE EARLY INTERVENTION AND TREATMENT OF LIVER CANCER PCT PCT PCT/US2025/059785 Pending
NEI E-116-2023-0-EP-01 TYROSINASE GENE THERAPY FOR OCULOCUTANEOUS ALBINISM TYPE 1A EP National Stage 24734696.8 Pending
NCI E-089-2023-0-US-02 EPIDITHIODIKETOPIPERAZINE ANALOGS AND METHODS OF USE US National Stage 19/492,894 Pending
NCATS E-046-2021-0-US-03 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US CON 19/418,392 Pending
NIAID E-044-2024-0-PC-01 COMPOSITIONS AND METHODS FOR EDITING THE HUMAN ALPHA KINASE 1 (ALPK1) GENE AND TREATING ROSAH SYNDROME PCT PCT PCT/US2025/059432 Pending
NHLBI E-121-2016-2-US-02 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE US DIV 19/416,316 Pending
NIAID E-102-2025-0-KR-01 AN ANTIBODY SPECIFICALLY BINDING TO SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS ANTIGEN AND USE THEREOF KR ORD 10-2025-0196127 Pending
NIAID E-153-2019-1-NZ-17 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE NZ DIV 828143 Pending
NEI E-015-2019-0-AU-03 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE AU DIV 2025279683 Pending
NCI E-132-2023-0-US-02 T CELL RECEPTORS TARGETING RAS WITH G12D, G12R, OR G12V MUTATION US National Stage 19/491,831 Pending
NCI E-245-2024-0-PC-01 MESOTHELIN-TARGETED CAR T CELLS WITH INCREASED ANTI-TUMOR EFFICACY,
PERSISTENCE AND RESILIENCE AND USE THEREOF FOR THE TREATMENT OF MESOTHELINPOSITIVE CANCERS 		PCT PCT PCT/US2025/058898 Pending
NIAID E-206-2024-0-PC-01 MONOCLONAL ANTIBODIES TO NIPAH VIRUS AND THEIR USE PCT PCT PCT/US2025/058844 Pending
NIAID E-135-2025-0-EP-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE EP National Stage 24731156.6 Pending
NIAID E-135-2025-0-AU-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE AU National Stage 2024269989 Pending
NIAID E-135-2025-0-NZ-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE NZ National Stage 828065 Pending
NIAID E-081-2013-4-RU-21 Prefusion RSV F Proteins And Their Use RU DIV 2025134591 Pending
NIAID E-135-2025-0-RU-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE RU National Stage 2025134565 Pending
NIEHS E-184-2023-0-EP-01 METHOD AND APPARATUS FOR CRYOGENIC-ELECTRON MICROSCOPY SAMPLE PREPARATION EP National Stage 24820039.6 Pending
NCI E-003-2025-0-PC-01 LINKER FOR ANTIBODY-DRUG CONJUGATES AND ANTIBODY-DRUG CONJUGATES COMPRISING THE LINKER PCT PCT PCT/US2025/058444 Pending
NCI E-079-2020-2-US-01 IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN US CON 19/410,830 Pending
NIEHS E-184-2023-0-US-02 METHOD AND APPARATUS FOR CRYOGENIC-ELECTRON MICROSCOPY SAMPLE PREPARATION US National Stage 19/490,791 Pending
NIAID E-086-2020-0-US-04 SARS-COV-2 VACCINE US CON 19/409,429 Pending
NIAID E-165-2023-0-AU-01 BISPECIFIC ANTIBODIES THAT BROADLY TARGET CORONAVIRUSES AU National Stage 2024300009 Pending
NIAID E-118-2023-2-US-02 VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION US National Stage 19/489,061 Pending
NIAID E-169-2023-0-US-02 HIV-1 ENVELOPE TRIPLE TANDEM TRIMERS AND THEIR USE US National Stage 19/488,691 Pending
NIAID E-135-2025-0-JP-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE JP National Stage 2025-564862 Pending
NIAID E-135-2025-0-KR-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE KR National Stage 10-2025-7039620 Pending
NHGRI E-134-2023-0-EP-01 SYNTHETIC MMAB GENES AND AAV VECTORS TO TREAT COBALAMIN B DEFICIENCY EP National Stage 24724684.6 Pending
NIEHS E-164-2023-0-EP-01 APOE-ACTIVATING NONCODING RNA (ERNA) AND USES THEREOF EP National Stage 24800521.7 Pending
NCI E-042-2014-0-IL-01 Chimeric Antigen Receptors Targeting CD-19 IL DIV 324883 Pending
NIAID E-240-2023-0-HK-01 VACCINES AGAINST CORONAVIRUSES HK EP 62025115535.9 Pending
NEI E-116-2023-0-CA-01 TYROSINASE GENE THERAPY FOR OCULOCUTANEOUS ALBINISM TYPE 1A CA National Stage 3293242 Pending
NCI E-099-2023-1-US-02 T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME US National Stage 19/486,754 Pending
NEI E-116-2023-0-US-03 TYROSINASE GENE THERAPY FOR OCULOCUTANEOUS ALBINISM TYPE 1A US National Stage 19/486,763 Pending
NICHD E-115-2022-0-US-03 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL US CON 19/394,477 Pending
NIDA E-122-2022-0-US-03 ANTIBODIES AGAINST FENTANYL AND FENTANYL ANALOGS US DIV 19/391,233 Pending
NIAID E-135-2025-0-DZ-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE DZ National Stage 251639 Pending
NIAID E-240-2020-0-US-02 RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN US National Stage 19/484,594 Pending
NCATS E-114-2018-0-EP-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS EP DIV 25214810.1 Pending
NIAID E-081-2013-4-CA-01 Prefusion RSV F Proteins And Their Use CA DIV 3291895 Pending
NIAID E-135-2025-0-BR-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE BR National Stage BR112025024522-8 Pending
NCI E-129-2023-0-US-02 SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF US National Stage 19/482,967 Pending
NIAID E-135-2025-0-IL-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE IL National Stage 324538 Pending
NIAID E-135-2025-0-SA-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE SA National Stage 1120258315 Pending
NIAID E-135-2025-0-MX-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE MX National Stage MX/a/2025/013368 Pending
NIAID E-135-2025-0-CN-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE CN National Stage 202480031207.7 Pending
NCI E-097-2018-0-MX-01 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES MX DIV MX/a/2025/013272 Pending